These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 30191830)

  • 1. A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
    Miller WC; Hoffman IF; Hanscom BS; Ha TV; Dumchev K; Djoerban Z; Rose SM; Latkin CA; Metzger DS; Lancaster KE; Go VF; Dvoriak S; Mollan KR; Reifeis SA; Piwowar-Manning EM; Richardson P; Hudgens MG; Hamilton EL; Sugarman J; Eshleman SH; Susami H; Chu VA; Djauzi S; Kiriazova T; Bui DD; Strathdee SA; Burns DN
    Lancet; 2018 Sep; 392(10149):747-759. PubMed ID: 30191830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis.
    Lancaster KE; Hoffman IF; Hanscom B; Ha TV; Dumchev K; Susami H; Rose S; Go VF; Reifeis SA; Mollan KR; Hudgens MG; Piwowar-Manning EM; Richardson P; Dvoriak S; Djoerban Z; Kiriazova T; Zeziulin O; Djauzi S; Ahn CV; Latkin C; Metzger D; Burns DN; Sugarman J; Strathdee SA; Eshleman SH; Clarke W; Donnell D; Emel L; Sunner LE; McKinstry L; Sista N; Hamilton EL; Lucas JP; Duong BD; Van Vuong N; Sarasvita R; Miller WC;
    J Int AIDS Soc; 2018 Oct; 21(10):e25195. PubMed ID: 30350406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes and risk factors of death among people who inject drugs in Indonesia, Ukraine and Vietnam: findings from HPTN 074 randomized trial.
    Dumchev K; Guo X; Ha TV; Djoerban Z; Zeziulin O; Go VF; Sarasvita R; Metzger DS; Latkin CA; Rose SM; Piwowar-Manning E; Richardson P; Hanscom B; Lancaster KE; Miller WC; Hoffman IF
    BMC Infect Dis; 2023 May; 23(1):319. PubMed ID: 37170118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Client and Provider Perspectives on Antiretroviral Treatment Uptake and Adherence Among People Who Inject Drugs in Indonesia, Ukraine and Vietnam: HPTN 074.
    Go VF; Hershow RB; Kiriazova T; Sarasvita R; Bui Q; Latkin CA; Rose S; Hamilton E; Lancaster KE; Metzger D; Hoffman IF; Miller WC
    AIDS Behav; 2019 Apr; 23(4):1084-1093. PubMed ID: 30306437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV clinic-based buprenorphine plus naloxone versus referral for methadone maintenance therapy for treatment of opioid use disorder in HIV clinics in Vietnam (BRAVO): an open-label, randomised, non-inferiority trial.
    Korthuis PT; King C; Cook RR; Khuyen TT; Kunkel LE; Bart G; Nguyen T; Thuy DT; Bielavitz S; Nguyen DB; Tam NTM; Giang LM
    Lancet HIV; 2021 Feb; 8(2):e67-e76. PubMed ID: 33539760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV incidence among people who inject drugs (PWIDs) in Ukraine: results from a clustered randomised trial.
    Booth RE; Davis JM; Dvoryak S; Brewster JT; Lisovska O; Strathdee SA; Latkin CA
    Lancet HIV; 2016 Oct; 3(10):e482-9. PubMed ID: 27658879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective "test-and-treat" demonstration project among people who inject drugs in Vietnam.
    Nguyen HH; Bui DD; Dinh TT; Pham LQ; Nguyen VT; Tran TH; Pham TH; Nguyen SM; Suthar AB; Do NT; Ford N; Lo YR; Nguyen LH; Giang LM; Kato M;
    J Int AIDS Soc; 2018 Jul; 21(7):e25151. PubMed ID: 29984473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV drug resistance in persons who inject drugs enrolled in an HIV prevention trial in Indonesia, Ukraine, and Vietnam: HPTN 074.
    Palumbo PJ; Zhang Y; Fogel JM; Guo X; Clarke W; Breaud A; Richardson P; Piwowar-Manning E; Hart S; Hamilton EL; Hoa NTK; Liulchuk M; Anandari L; Ha TV; Dumchev K; Djoerban Z; Hoffman I; Hanscom B; Miller WC; Eshleman SH
    PLoS One; 2019; 14(10):e0223829. PubMed ID: 31600343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study.
    Kiriazova T; Go VF; Hershow RB; Hamilton EL; Sarasvita R; Bui Q; Lancaster KE; Dumchev K; Hoffman IF; Miller WC; Latkin CA
    Harm Reduct J; 2020 Oct; 17(1):69. PubMed ID: 32998731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing an Individually Tailored Multilevel Intervention to Increase Engagement in HIV and Substance Use Treatment Among People Who Inject Drugs With HIV: HPTN 074.
    Lancaster KE; Miller WC; Kiriazova T; Sarasvita R; Bui Q; Ha TV; Dumchev K; Susami H; Hamilton EL; Rose S; Hershow RB; Go VF; Metzger D; Hoffman IF; Latkin CA
    AIDS Educ Prev; 2019 Apr; 31(2):95-110. PubMed ID: 30917014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptoms and use of HIV care and medication-assisted treatment among people with HIV who inject drugs.
    Zeziulin O; Mollan KR; Shook-Sa BE; Hanscom B; Lancaster KE; Dumchev K; Go VF; Chu VA; Kiriazova T; Syarif Z; Dvoryak S; Reifeis SA; Hamilton E; Sarasvita R; Rose S; Richardson P; Clarke W; Latkin CA; Metzger DS; Hoffman IF; Miller WC
    AIDS; 2021 Mar; 35(3):495-501. PubMed ID: 33252489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis.
    Low AJ; Mburu G; Welton NJ; May MT; Davies CF; French C; Turner KM; Looker KJ; Christensen H; McLean S; Rhodes T; Platt L; Hickman M; Guise A; Vickerman P
    Clin Infect Dis; 2016 Oct; 63(8):1094-1104. PubMed ID: 27343545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality and virological failure among HIV-infected people who inject drugs on antiretroviral treatment in China: An observational cohort study.
    Zhao Y; Zhang M; Shi CX; Huang J; Zhang F; Rou K; Wu Z
    Drug Alcohol Depend; 2017 Jan; 170():189-197. PubMed ID: 27987476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial.
    Crowell TA; Colby DJ; Pinyakorn S; Sacdalan C; Pagliuzza A; Intasan J; Benjapornpong K; Tangnaree K; Chomchey N; Kroon E; de Souza MS; Tovanabutra S; Rolland M; Eller MA; Paquin-Proulx D; Bolton DL; Tokarev A; Thomas R; Takata H; Trautmann L; Krebs SJ; Modjarrad K; McDermott AB; Bailer RT; Doria-Rose N; Patel B; Gorelick RJ; Fullmer BA; Schuetz A; Grandin PV; O'Connell RJ; Ledgerwood JE; Graham BS; Tressler R; Mascola JR; Chomont N; Michael NL; Robb ML; Phanuphak N; Ananworanich J;
    Lancet HIV; 2019 May; 6(5):e297-e306. PubMed ID: 31000477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engaging People Who Inject Drugs Living With HIV in Antiretroviral Treatment and Medication for Opioid Use Disorder: Extended Follow-up of HIV Prevention Trials Network (HPTN) 074.
    Lancaster KE; Mollan KR; Hanscom BS; Shook-Sa BE; Ha TV; Dumchev K; Djoerban Z; Rose SM; Latkin CA; Metzger DS; Go VF; Dvoriak S; Reifeis SA; Piwowar-Manning EM; Richardson P; Hudgens MG; Hamilton EL; Eshleman SH; Susami H; Chu VA; Djauzi S; Kiriazova T; Nhan DT; Burns DN; Miller WC; Hoffman IF
    Open Forum Infect Dis; 2021 Aug; 8(8):ofab281. PubMed ID: 34458390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid access to antiretroviral therapy, receipt of naltrexone, and strengths-based case management versus standard of care for HIV viral load suppression in people with HIV who inject drugs in Russia (LINC-II): an open-label, randomised controlled trial.
    Samet JH; Blokhina E; Cheng DM; Rosen S; Lioznov D; Lunze K; Truong V; Gnatienko N; Quinn E; Bushara N; Raj A; Krupitsky E
    Lancet HIV; 2023 Sep; 10(9):e578-e587. PubMed ID: 37659841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trial.
    Wirth KE; Gaolathe T; Pretorius Holme M; Mmalane M; Kadima E; Chakalisa U; Manyake K; Matildah Mbikiwa A; Simon SV; Letlhogile R; Mukokomani K; van Widenfelt E; Moyo S; Bennett K; Leidner J; Powis KM; Lebelonyane R; Alwano MG; Jarvis J; Dryden-Peterson SL; Kgathi C; Moore J; Bachanas P; Raizes E; Abrams W; Block L; Sento B; Novitsky V; El-Halabi S; Marukutira T; Mills LA; Sexton C; Pals S; Shapiro RL; Wang R; Lei Q; DeGruttola V; Makhema J; Essex M; Lockman S; Tchetgen Tchetgen EJ
    Lancet HIV; 2020 Jun; 7(6):e422-e433. PubMed ID: 32504575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial.
    Gross R; Zheng L; La Rosa A; Sun X; Rosenkranz SL; Cardoso SW; Ssali F; Camp R; Godfrey C; Cohn SE; Robbins GK; Chisada A; Wallis CL; Reynolds NR; Lu D; Safren SA; Hosey L; Severe P; Collier AC;
    Lancet HIV; 2015 Jan; 2(1):e12-9. PubMed ID: 26424232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.